Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology

INTRODUCTION: Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transp...

Descripción completa

Detalles Bibliográficos
Autores principales: Falavigna, Maicon, Colpani, Verônica, Stein, Cinara, Azevedo, Luciano Cesar Pontes, Bagattini, Angela Maria, de Brito, Gabriela Vilela, Chatkin, José Miguel, Cimerman, Sergio, Corradi, Mirian de Freitas Dal Ben, da Cunha, Clovis Arns, de Medeiros, Flávia Cordeiro, de Oliveira Junior, Haliton Alves, Fritscher, Leandro Genehr, Gazzana, Marcelo Basso, Gräf, Débora Dalmas, Marra, Lays Pires, Matuoka, Jessica Yumi, Nunes, Michelle Silva, Pachito, Daniela Vianna, Pagano, Cássia Garcia Moraes, Parreira, Patrícia do Carmo Silva, Riera, Rachel, Silva Júnior, Amilton, Tavares, Bruno de Melo, Zavascki, Alexandre Prehn, Rosa, Regis Goulart, Dal-Pizzol, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Medicina Intensiva Brasileira - AMIB 2020
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405746/
https://www.ncbi.nlm.nih.gov/pubmed/32667444
http://dx.doi.org/10.5935/0103-507X.20200039

Ejemplares similares

Ejemplares similares